«EXACO»: Follow-up on 4 years of exacerbations of a patients' cohort affected with chronic obstructive pulmonary disease;«EXACO»: Suivi sur 4 ans des exacerbations d'une cohorte de patients atteints de bronchopneumopathie chronique obstructive

Revue des Maladies Respiratoires

Volumn 23, Issue 4, 2006, Pages 377-384

  Tillie Leblond, I ^a   Masure, F ^b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Groupe Médical Saint Remi   (France)

Author keywords

Bronchitis; Cohort; COPD; Exacerbation

Indexed keywords

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HEALTH SURVEY; HUMAN; INTERVIEW; LUNG FUNCTION TEST; OBSERVATIONAL STUDY; PHYSICIAN; TELEPHONE; ALGORITHM; COHORT ANALYSIS; FRANCE; HOSPITALIZATION; PATHOPHYSIOLOGY; PEAK EXPIRATORY FLOW; PROSPECTIVE STUDY;

ALGORITHMS; COHORT STUDIES; FORCED EXPIRATORY VOLUME; FRANCE; HUMANS; PEAK EXPIRATORY FLOW RATE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX;

EID: 33750459346     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1019/20064122     Document Type: Article

References (35)

1. Recommandations pour la prise en charge de la BPCO, SPLF. Rev Mal Respir 2003 ; 1 : 1-4.
2. Wedzicha JA, Donaldson GC : Exacerbations of chronic obstructive pulmonary disease. Respir Care 2003 ; 48 : 1204-15.
3. Siafakas N M Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, Yernault JC, Decramer M, Higenbottam T, Postma DS : Optimal assessment and management of patients with chronic obstructive pulmonary disease COPD. Eur Respir J 1995 ; 8 : 1398-420.
4. Croxton TL, Weinmann GG, Senior RM, Wise RA, Crapo JD, Buist AS : Clinical research in chronic obstructive pulmonary disease: needs and opportunities. Am J Respir Crit Care Med 2003 ; 167 : 1142-9.
5. Leuenberger P, Anderhub HP, Brandli O, Keller R, Knoblauch A, Kuhn M, Perruchoud AP, Rochat T, Russi E, Villiger B, Zellweger JP : Management 1997 of chronic obstructive pulmonary disease. Schweiz Med Wochenschr 1997 ; 127 : 766-82.
6. The COPD Guidelines Group of Standards of Care Committee of the BTS : BTS Guidelines for the Management of Chronic Obstructive Pulmonary Disease. Thorax 1997 ; 52 : S1-28.
7. Burge S, Wedzicha JA : COPD exacerbations: definitions and classifications. Eur Respir J 2003 ; 21 : 46s-53s.
8. Global Initiative for Chronic Obstructive Lung disease. Global Strategy For the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease : NHLBI/WHO Workshop Report. National Institute of Health; updated 2004. NIH Publication No2701. Available at http://www.goldcopd.com
9. ENCPA-Reseau Europeen des Associations de Patients atteints de BPCO; Federation Francaise des Associations et Amicales d'Insuffisants Respiratoires : Le manifeste des patients atteints de BPCO, Rev Mal Respir 2003 ; 20 : 471-76.
10. Calverley PM, Walker P : Chronic obstructive pulmonary disease. Lancet 2003 ; 362 : 1053-61.
11. Warne PJ : COPD: Market opportunities for new therapies and diagnostics. Richmond, Surrey, UK. PJB Publications Ltd; 2000. BS1085
12. Rennard S, Decramer M, Calverley PM, Pride NB, Soriano JB, Vermeire PA, Vestbo J : Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J 2002 ; 20 : 799-805.
13. Snider GL : Facteurs de risque et populations à risque. Rev Mal Respir 1998 ; 15 : 2S5-2S9.
14. Buist AS : The US Lung Health Study. Respirology 1997 ; 2 : 303-7.
15. Viegi G, Paoletti P, Carrozzi L, Vellutini M, Diviggiano E, Di Pede C, Pistelli G, Giutini G, Lebowitz MD : Prevalence rates of respiratory symptoms in Italian general population samples exposed to different levels of air pollution. Environ Health Perspect 1991 ; 94 : 95-9.
16. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ : The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004 ; 350 : 1005-12.
17. Malher DA, Mackowiak JI : Evaluation of the Short-Form 36-item questionnaire to measure health related quality of life in patients with COPD. Chest 1995 ; 107 : 1585-9.
18. Hajiro T, Nishimura K, Tsukino, M Ikeda A, Koyama H, Izumi T: Comparison of discriminative properties among disease-specific questionnaires for measuring health related quality of life in patients with COPD. Am J Respir Crit Care Med 1998 ; 157 : 785-90.
19. Bouchet C, Guillemin F, Hoang T, Cornette A, Briancon S : Validation du questionnaire Saint George's pour mesurer la qualité de vie chez les insuffisants respiratoires chroniques. Rev Mal Respir 1996 ; 13 : 43-46.
20. Hajiro T, Nishimura K, Jones PW, Tsukino M, Ikeda A, Koyama H, Izumi T. A novel, short, and simple questionnaire to measure health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999 ; 159 : 1874-8.
21. Carone M, Bertolotti G, Anchisi F, Zotti AM, Donner CF, Jones PW : Analysis of factors that characterize health impairment in patients with chronic respiratory failure. Eur Respir J 1999 ; 13 : 1293-300.
22. Ferrer M, Alonso J, Morera J Marrades RM, Khalaf A, Aguar MC, Plaza V, Prieto, L, Anto JM : Chronic obstructive pulmonary disease stage and health-related quality of life. Ann Intern Med 1997 ; 127 : 1072-9.
23. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T : A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest 1999 ; 116 : 1632-37.
24. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA : Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998 ; 157 : 1418-22.
25. Jones PW: Évaluation de l'obstruction bronchique. Dyspnée, qualité de vie. Rev Mal Respir 1998 ; 15 : 2S25-2S28.
26. Jones PW: Évaluation de l'obstruction bronchique. Dyspnée, qualité de vie. Rev Mal Respir 1998 ; 15 : 2S25-2S28
27. Rodriguez-Roisin R : Toward a consensus definition for COPD exacerbation. Chest 2000 ; 117 : 398S-401S.
28. Donaldson GC, Seemungal TAR, Bhowmik A, Wedzicha JA : Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002 ; 57 : 847-52.
29. Wedzicha JA : Exacerbations: etiology and pathophysiologic mechanisms. Chest 2002 ; 121 : 136S-141S.
30. Patel IS, Seemungal TA, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha JA : Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002 ; 57 : 759-64.
31. Kanner RE, Anthonisen NR, Connett JE: Lower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease - Results from the Lung Health Study. Am J Respir Crit Care Med 2001 ; 164 : 358-64.
32. Stoller JK : Acute exacerbation of chronic obstructive pulmonary disease. N Engl J Med 2002 ; 346 : 988-94.
33. O'Reilly JF, Williams AE, Rice L, Holt K : Impact of definition when assessing the cumulative incidence of exacerbation amongst a cohort of primary care COPD patients. Abstract presented at ERS 2004, Glasgow, Scotland. 4-8 September 2004.
34. e édition, Flammarion ed, Paris, 1993.
35. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA : Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002 ; 57 : 847-52.